The elevated TXNIP expression found in human islets from individuals with T1D and T2D and the detrimental effects of increased TXNIP on beta cell survival and islet function provided a strong rationale for attempting to therapeutically inhibit islet TXNIP expression. This evidence concerns the gene TXNIP and type 2 diabetes mellitus.